Triaminic, Theraflu products made at Novartis in Lincoln recalled

2013-01-31T15:42:00Z 2013-09-05T17:50:05Z Triaminic, Theraflu products made at Novartis in Lincoln recalledBy MATT OLBERDING / Lincoln Journal Star

Two products made at the idled Lincoln Novartis plant have been recalled.

The company Thursday voluntarily recalled certain lots of Triaminic and Theraflu syrups because of potentially faulty child-resistant caps.

According to the Consumer Product Safety Commission, there have been 12 reports of children unscrewing the locked caps, including four reports of children ingesting the product. One child required medical attention.

Novartis said the recall covers 142 lots of Triaminic Syrups and 41 lots of Theraflu Warming Relief Syrups that were manufactured in Lincoln and distributed distributed between May 24, 2010, and December 21, 2011. A list of the affected products and more information about the recall can be found at

The company said in a news release that about 97 percent of the recalled products have been consumed by customers, returned to Novartis or quarantined at a Novartis warehouse, and it is likely that very little product remains on shelves or in consumers' homes.

The recall is the latest problem related to the Lincoln Novartis plant. The plant shut down in December 2011 after the Food and Drug Administration noted multiple quality-control problems, including potential cross-contamination of medications manufactured there.

In January 2012, the FDA warned that high-powered painkillers Novartis was making for another company could be contaminated, although it stopped short of recalling the products.

In February 2012, Glaxo SmithKline recalled blood pressure drug DynaCirc CR, which Novartis had been making in Lincoln.

Novartis said last week during its quarterly earnings announcement that it has resumed some limited production at the Lincoln plant and hopes to resume more production in the first half of the year.

The company has been manufacturing some over-the-counter medications, including Triaminic, at another undisclosed site.

A Novartis spokeswoman said Thursday that Triaminic products currently found on store shelves are likely to be newly manufactured products and are safe.

"If the lot number is seven digits long and has two letters as its second and third digits, it is not part of the voluntary recall, as the tamper-evident seal does not affect the child-resistant cap," said Julie Masow, the spokeswoman.

Reach Matt Olberding at 473-2647 or

Copyright 2016 All rights reserved. This material may not be published, broadcast, rewritten or redistributed.